Search results for "Atrial fibrillation"


 
Results 91 - 100 of about 205 for "Atrial fibrillation".
Sort by: Relevance | Newest | Oldest

New warnings for gabapentinoids; other drugs approved

This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2020/02/new-warnings-for-gabapentinoids-other-drugs-approved.htm
1 Feb 2020

New drugs could improve anticoagulation rates

Dabigatran and rivaroxaban spare patients the need for regular blood checks, but warfarin is less expensive and has an antidote to reverse bleeding, if needed. Does the convenience of the new generation of drugs and the potential to increase compliance with therapy outweigh their downsides?.
https://immattersacp.org/archives/2012/04/anticoagulation.htm
1 Apr 2012

Study finds masked and white coat hypertension prevalent and associated with higher risk of adverse cardiovascular events

Both white coat hypertension and masked hypertension were independently associated with increased biomarkers for organ damage, as well as higher risk of cardiovascular events compared with normal blood pressure, even after adjustment for traditional cardiovascular risk factors.
https://immattersacp.org/weekly/archives/2015/11/10/1.htm
10 Nov 2015

Benefits of thyroid screening unclear, Task Force says

Researchers for the U.S. Preventive Services Task Force (USPSTF) suggested in a review that more research is needed to determine the benefits of screening asymptomatic individuals for thyroid dysfunction.
https://immattersacp.org/weekly/archives/2014/10/28/2.htm
28 Oct 2014

New drugs approved for acute coronary syndromes, HIV

Recalls, warnings, and approvals.
https://immattersacp.org/archives/2011/10/fda.htm
1 Oct 2011

Comparison with warfarin comes out well for dabigatran

Dabigatran (Pradaxa) was associated with a lower risk of clot-related strokes, intracranial hemorrhage, and death than warfarin, according to a recent study conducted by the FDA.
https://immattersacp.org/weekly/archives/2014/05/20/8.htm
20 May 2014

BMJ investigation claims safety info about dabigatran withheld by manufacturer

The makers of dabigatran allegedly failed to share information with regulators that would make using the drug safer—specifically, that monitoring plasma levels of the drug and adjusting doses accordingly could significantly reduce major bleeding, a new BMJ investigation found.
https://immattersacp.org/weekly/archives/2014/07/29/4.htm
29 Jul 2014

The next edition is online and coming to your mailbox

Candidates announced for Board of Governors Chair-electACP supports Saudi physicians upholding medical ethicsACP provides ethical guidance on using incentives to promote personal responsibility
https://immattersacp.org/weekly/archives/2010/09/14/8.htm
14 Sep 2010

Taking a drink: what patients should know

Alcohol is associated with so many benefits and harms that it's hard to know where to start talking to patients about using it. One place might be alcohol misuse and abuse. Teach patients where they fall on the continuum of drinking behavior.
https://immattersacp.org/archives/2013/01/alcohol.htm
1 Jan 2013

New report proposes solutions to drug shortages

This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2020/01/new-report-proposes-solutions-to-drug-shortages.htm
1 Jan 2020

Result Page: Prev   5   6   7   8   9   10   11   12   13   14   Next